[TNXP] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
16-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -427.32%
YoY- -177.81%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 2,208 0 9,027 0 0 0 0 -
PBT -78,776 -28,356 -23,140 -23,553 -14,179 -5,840 -6,087 53.16%
Tax 0 29,002 -196 0 0 0 0 -
NP -78,776 -28,356 -27,395 -23,553 -14,179 -5,840 -6,087 53.16%
Tax Rate - - - - - - - -
Total Cost 80,984 28,356 36,422 23,553 14,179 5,840 6,087 53.87%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -3,567.75 0.00 -254.17 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -19.28 -85.71 -244.55 -449.35 0.00 0.00 0.00 -
EPS Diluted -19.28 -85.71 -244.55 -449.35 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.